Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROEを2つのコンポーネントに分解

AbbVie Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2024/09/30 84.91% = 3.57% × 23.78
2024/06/30 78.77% = 3.76% × 20.94
2024/03/31 74.85% = 4.03% × 18.59
2023/12/31 46.94% = 3.61% × 13.00
2023/09/30 53.86% = 4.78% × 11.26
2023/06/30 67.50% = 6.42% × 10.52
2023/03/31 57.14% = 5.64% × 10.14
2022/12/31 68.60% = 8.53% × 8.04
2022/09/30 83.83% = 9.49% × 8.84
2022/06/30 86.24% = 8.83% × 9.77
2022/03/31 76.64% = 8.71% × 8.80
2021/12/31 74.91% = 7.88% × 9.51
2021/09/30 55.60% = 5.06% × 10.99
2021/06/30 53.01% = 4.50% × 11.77
2021/03/31 37.63% = 3.43% × 10.98
2020/12/31 35.30% = 3.07% × 11.51
2020/09/30 48.34% = 4.93% × 9.80
2020/06/30 47.30% = 4.65% × 10.17
2020/03/31 = 9.25% ×
2019/12/31 = 8.84% ×
2019/09/30 = ×
2019/06/30 = ×
2019/03/31 = ×

レポートに基づく: 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第3 四半期に株主資本利益率(ROE)が上昇した主な理由は、財務レバレッジ比率の上昇です。


ROEを3つの要素に分解

AbbVie Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2024/09/30 84.91% = 9.22% × 0.39 × 23.78
2024/06/30 78.77% = 9.71% × 0.39 × 20.94
2024/03/31 74.85% = 11.02% × 0.37 × 18.59
2023/12/31 46.94% = 8.95% × 0.40 × 13.00
2023/09/30 53.86% = 11.81% × 0.40 × 11.26
2023/06/30 67.50% = 15.50% × 0.41 × 10.52
2023/03/31 57.14% = 13.37% × 0.42 × 10.14
2022/12/31 68.60% = 20.39% × 0.42 × 8.04
2022/09/30 83.83% = 23.19% × 0.41 × 8.84
2022/06/30 86.24% = 22.04% × 0.40 × 9.77
2022/03/31 76.64% = 22.00% × 0.40 × 8.80
2021/12/31 74.91% = 20.54% × 0.38 × 9.51
2021/09/30 55.60% = 13.66% × 0.37 × 10.99
2021/06/30 53.01% = 12.40% × 0.36 × 11.77
2021/03/31 37.63% = 10.28% × 0.33 × 10.98
2020/12/31 35.30% = 10.08% × 0.30 × 11.51
2020/09/30 48.34% = 18.16% × 0.27 × 9.80
2020/06/30 47.30% = 19.20% × 0.24 × 10.17
2020/03/31 = 24.77% × 0.37 ×
2019/12/31 = 23.69% × 0.37 ×
2019/09/30 = × ×
2019/06/30 = × ×
2019/03/31 = × ×

レポートに基づく: 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第3 四半期に株主資本利益率(ROE)が上昇した主な理由は、財務レバレッジ比率の上昇です。


ROAを2つのコンポーネントに分解

AbbVie Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2024/09/30 3.57% = 9.22% × 0.39
2024/06/30 3.76% = 9.71% × 0.39
2024/03/31 4.03% = 11.02% × 0.37
2023/12/31 3.61% = 8.95% × 0.40
2023/09/30 4.78% = 11.81% × 0.40
2023/06/30 6.42% = 15.50% × 0.41
2023/03/31 5.64% = 13.37% × 0.42
2022/12/31 8.53% = 20.39% × 0.42
2022/09/30 9.49% = 23.19% × 0.41
2022/06/30 8.83% = 22.04% × 0.40
2022/03/31 8.71% = 22.00% × 0.40
2021/12/31 7.88% = 20.54% × 0.38
2021/09/30 5.06% = 13.66% × 0.37
2021/06/30 4.50% = 12.40% × 0.36
2021/03/31 3.43% = 10.28% × 0.33
2020/12/31 3.07% = 10.08% × 0.30
2020/09/30 4.93% = 18.16% × 0.27
2020/06/30 4.65% = 19.20% × 0.24
2020/03/31 9.25% = 24.77% × 0.37
2019/12/31 8.84% = 23.69% × 0.37
2019/09/30 = ×
2019/06/30 = ×
2019/03/31 = ×

レポートに基づく: 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第3 四半期の総資産利益率(ROA)が低下した主な理由は、純利益率で測定した収益性の低下です。